Structure

Physi-Chem Properties

Molecular Weight:  685.27
Volume:  664.119
LogP:  2.267
LogD:  1.494
LogS:  -4.464
# Rotatable Bonds:  12
TPSA:  190.92
# H-Bond Aceptor:  14
# H-Bond Donor:  1
# Rings:  6
# Heavy Atoms:  14

MedChem Properties

QED Drug-Likeness Score:  0.324
Synthetic Accessibility Score:  6.479
Fsp3:  0.686
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.343
MDCK Permeability:  0.0001231860078405589
Pgp-inhibitor:  0.999
Pgp-substrate:  0.101
Human Intestinal Absorption (HIA):  0.824
20% Bioavailability (F20%):  0.803
30% Bioavailability (F30%):  0.984

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.089
Plasma Protein Binding (PPB):  33.635826110839844%
Volume Distribution (VD):  1.377
Pgp-substrate:  31.85293960571289%

ADMET: Metabolism

CYP1A2-inhibitor:  0.01
CYP1A2-substrate:  0.108
CYP2C19-inhibitor:  0.025
CYP2C19-substrate:  0.091
CYP2C9-inhibitor:  0.026
CYP2C9-substrate:  0.02
CYP2D6-inhibitor:  0.01
CYP2D6-substrate:  0.035
CYP3A4-inhibitor:  0.776
CYP3A4-substrate:  0.447

ADMET: Excretion

Clearance (CL):  2.489
Half-life (T1/2):  0.771

ADMET: Toxicity

hERG Blockers:  0.313
Human Hepatotoxicity (H-HT):  0.937
Drug-inuced Liver Injury (DILI):  0.973
AMES Toxicity:  0.021
Rat Oral Acute Toxicity:  0.495
Maximum Recommended Daily Dose:  0.114
Skin Sensitization:  0.176
Carcinogencity:  0.038
Eye Corrosion:  0.003
Eye Irritation:  0.014
Respiratory Toxicity:  0.314

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC238278

Natural Product ID:  NPC238278
Common Name*:   Euphorbialoid G
IUPAC Name:   n.a.
Synonyms:   euphorbialoid G
Standard InCHIKey:  YAXJAINVCZAYMP-YFJLUURQSA-N
Standard InCHI:  InChI=1S/C35H43NO13/c1-8-22(40)47-25-16(2)12-35(43)24(25)29(45-17(3)37)34-15-44-33(7,31(35)46-18(4)38)27(34)23-21(13-32(23,6)49-19(5)39)26(28(34)41)48-30(42)20-10-9-11-36-14-20/h9-11,14,16,21,23-27,29,31,43H,8,12-13,15H2,1-7H3/t16-,21+,23-,24+,25-,26+,27-,29+,31-,32-,33+,34-,35+/m0/s1
SMILES:  CCC(=O)O[C@H]1[C@@H](C)C[C@]2([C@H]1[C@@H](OC(=O)C)[C@]13CO[C@@]([C@@H]2OC(=O)C)([C@@H]3[C@@H]2[C@H]([C@H](C1=O)OC(=O)c1cccnc1)C[C@]2(C)OC(=O)C)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2030585
PubChem CID:   70681568
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0002995] Pentacarboxylic acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO12377 Euphorbia prolifera Species Euphorbiaceae Eukaryota Roots Kunming, Yunnan Province, China 2010-JUL PMID[21928782]
NPO12377 Euphorbia prolifera Species Euphorbiaceae Eukaryota n.a. root n.a. PMID[21928782]
NPO12377 Euphorbia prolifera Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[22560584]
NPO12377 Euphorbia prolifera Species Euphorbiaceae Eukaryota Roots n.a. n.a. PMID[7775985]
NPO12377 Euphorbia prolifera Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO12377 Euphorbia prolifera Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT34 Cell Line BV-2 Mus musculus IC50 = 48700.0 nM PMID[482823]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC238278 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9665 High Similarity NPC213143
0.9378 High Similarity NPC233727
0.9336 High Similarity NPC311196
0.9336 High Similarity NPC134384
0.9289 High Similarity NPC285411
0.9289 High Similarity NPC14116
0.9198 High Similarity NPC475601
0.9179 High Similarity NPC193361
0.9179 High Similarity NPC62844
0.9091 High Similarity NPC187494
0.907 High Similarity NPC96801
0.907 High Similarity NPC150698
0.8986 High Similarity NPC40919
0.8986 High Similarity NPC470189
0.8945 High Similarity NPC35208
0.894 High Similarity NPC469748
0.8932 High Similarity NPC470190
0.8852 High Similarity NPC280473
0.8852 High Similarity NPC476467
0.8852 High Similarity NPC323551
0.8843 High Similarity NPC124029
0.8843 High Similarity NPC211920
0.8837 High Similarity NPC328154
0.8821 High Similarity NPC319556
0.881 High Similarity NPC51008
0.881 High Similarity NPC41724
0.8784 High Similarity NPC253482
0.8774 High Similarity NPC471016
0.8768 High Similarity NPC228331
0.8768 High Similarity NPC319128
0.875 High Similarity NPC477902
0.8726 High Similarity NPC470306
0.8726 High Similarity NPC207531
0.8721 High Similarity NPC477906
0.871 High Similarity NPC148860
0.8698 High Similarity NPC477912
0.8692 High Similarity NPC301368
0.8692 High Similarity NPC84815
0.8685 High Similarity NPC475408
0.8685 High Similarity NPC471014
0.8679 High Similarity NPC264674
0.8673 High Similarity NPC472553
0.8667 High Similarity NPC475648
0.8645 High Similarity NPC62367
0.8638 High Similarity NPC477910
0.8619 High Similarity NPC472752
0.8605 High Similarity NPC216428
0.8604 High Similarity NPC475426
0.8598 High Similarity NPC6981
0.8584 High Similarity NPC146824
0.8578 High Similarity NPC26881
0.8571 High Similarity NPC127720
0.8571 High Similarity NPC127026
0.8558 High Similarity NPC294579
0.8558 High Similarity NPC144779
0.8551 High Similarity NPC477909
0.8551 High Similarity NPC42678
0.8551 High Similarity NPC477907
0.8545 High Similarity NPC165837
0.8545 High Similarity NPC475362
0.8532 High Similarity NPC57797
0.8532 High Similarity NPC250807
0.8532 High Similarity NPC76565
0.8532 High Similarity NPC471980
0.8531 High Similarity NPC304179
0.8531 High Similarity NPC48042
0.8531 High Similarity NPC472550
0.8525 High Similarity NPC477903
0.8514 High Similarity NPC244839
0.8514 High Similarity NPC320324
0.8514 High Similarity NPC319880
0.8505 High Similarity NPC4421
0.8493 Intermediate Similarity NPC475137
0.8493 Intermediate Similarity NPC475498
0.8493 Intermediate Similarity NPC473850
0.8486 Intermediate Similarity NPC235364
0.8486 Intermediate Similarity NPC477911
0.8479 Intermediate Similarity NPC477901
0.8475 Intermediate Similarity NPC237702
0.8468 Intermediate Similarity NPC292416
0.8468 Intermediate Similarity NPC473689
0.8433 Intermediate Similarity NPC472555
0.8423 Intermediate Similarity NPC91125
0.8416 Intermediate Similarity NPC475600
0.8416 Intermediate Similarity NPC87152
0.8416 Intermediate Similarity NPC477787
0.8416 Intermediate Similarity NPC476110
0.8416 Intermediate Similarity NPC328186
0.8416 Intermediate Similarity NPC475631
0.8416 Intermediate Similarity NPC228377
0.8416 Intermediate Similarity NPC122968
0.8409 Intermediate Similarity NPC477900
0.8409 Intermediate Similarity NPC477899
0.84 Intermediate Similarity NPC38959
0.84 Intermediate Similarity NPC327904
0.8396 Intermediate Similarity NPC63041
0.8387 Intermediate Similarity NPC473115
0.8387 Intermediate Similarity NPC158020
0.8387 Intermediate Similarity NPC6576
0.8387 Intermediate Similarity NPC212768
0.8387 Intermediate Similarity NPC75600
0.8387 Intermediate Similarity NPC473089
0.8378 Intermediate Similarity NPC475644
0.8378 Intermediate Similarity NPC470486
0.8378 Intermediate Similarity NPC471190
0.8378 Intermediate Similarity NPC471977
0.8356 Intermediate Similarity NPC475406
0.8341 Intermediate Similarity NPC206343
0.8341 Intermediate Similarity NPC477908
0.8312 Intermediate Similarity NPC324619
0.8312 Intermediate Similarity NPC475315
0.8304 Intermediate Similarity NPC475303
0.8304 Intermediate Similarity NPC475596
0.8304 Intermediate Similarity NPC316841
0.8295 Intermediate Similarity NPC30570
0.8288 Intermediate Similarity NPC473506
0.827 Intermediate Similarity NPC473833
0.8268 Intermediate Similarity NPC475533
0.8267 Intermediate Similarity NPC30456
0.8235 Intermediate Similarity NPC477788
0.8213 Intermediate Similarity NPC471015
0.8194 Intermediate Similarity NPC327769
0.8194 Intermediate Similarity NPC170751
0.8157 Intermediate Similarity NPC292517
0.8101 Intermediate Similarity NPC475301
0.8101 Intermediate Similarity NPC85879
0.8101 Intermediate Similarity NPC326930
0.8101 Intermediate Similarity NPC53255
0.8091 Intermediate Similarity NPC162812
0.8069 Intermediate Similarity NPC148896
0.8069 Intermediate Similarity NPC180668
0.8069 Intermediate Similarity NPC471013
0.8067 Intermediate Similarity NPC13603
0.8066 Intermediate Similarity NPC470279
0.7975 Intermediate Similarity NPC471978
0.7932 Intermediate Similarity NPC10904
0.7901 Intermediate Similarity NPC328928
0.7878 Intermediate Similarity NPC471979
0.7844 Intermediate Similarity NPC475835
0.7834 Intermediate Similarity NPC289086
0.7689 Intermediate Similarity NPC476090
0.7639 Intermediate Similarity NPC471004
0.7535 Intermediate Similarity NPC103230
0.75 Intermediate Similarity NPC141385
0.749 Intermediate Similarity NPC37473
0.7478 Intermediate Similarity NPC253314
0.7477 Intermediate Similarity NPC309498
0.7397 Intermediate Similarity NPC324245
0.7397 Intermediate Similarity NPC320748
0.7376 Intermediate Similarity NPC32451
0.7376 Intermediate Similarity NPC155792
0.7376 Intermediate Similarity NPC328559
0.733 Intermediate Similarity NPC79223
0.7306 Intermediate Similarity NPC109922
0.7281 Intermediate Similarity NPC111732
0.7273 Intermediate Similarity NPC329024
0.7234 Intermediate Similarity NPC235885
0.7212 Intermediate Similarity NPC156044
0.7206 Intermediate Similarity NPC476516
0.7189 Intermediate Similarity NPC44354
0.7189 Intermediate Similarity NPC131273
0.7189 Intermediate Similarity NPC473441
0.7173 Intermediate Similarity NPC57690
0.7162 Intermediate Similarity NPC317672
0.7162 Intermediate Similarity NPC59033
0.7161 Intermediate Similarity NPC141428
0.7124 Intermediate Similarity NPC12944
0.7124 Intermediate Similarity NPC477043
0.7124 Intermediate Similarity NPC25442
0.7106 Intermediate Similarity NPC2395
0.7104 Intermediate Similarity NPC135950
0.7103 Intermediate Similarity NPC471997
0.7103 Intermediate Similarity NPC317010
0.7085 Intermediate Similarity NPC107123
0.7076 Intermediate Similarity NPC106593
0.7068 Intermediate Similarity NPC134637
0.7059 Intermediate Similarity NPC267926
0.7054 Intermediate Similarity NPC103361
0.7031 Intermediate Similarity NPC470280
0.702 Intermediate Similarity NPC471782
0.702 Intermediate Similarity NPC471583
0.7012 Intermediate Similarity NPC290529
0.6992 Remote Similarity NPC140311
0.6991 Remote Similarity NPC176371
0.6991 Remote Similarity NPC136573
0.698 Remote Similarity NPC278540
0.6976 Remote Similarity NPC476517
0.6975 Remote Similarity NPC473667
0.6975 Remote Similarity NPC266192
0.6968 Remote Similarity NPC114974
0.6955 Remote Similarity NPC70155
0.6952 Remote Similarity NPC55744
0.6951 Remote Similarity NPC476205
0.6951 Remote Similarity NPC476212
0.6951 Remote Similarity NPC476206
0.6951 Remote Similarity NPC476257
0.6951 Remote Similarity NPC476207
0.6951 Remote Similarity NPC146724
0.6951 Remote Similarity NPC476256
0.6951 Remote Similarity NPC259791

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC238278 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7731 Intermediate Similarity NPD8468 Phase 2
0.7718 Intermediate Similarity NPD8304 Clinical (unspecified phase)
0.7277 Intermediate Similarity NPD7396 Approved
0.7104 Intermediate Similarity NPD5975 Clinical (unspecified phase)
0.7082 Intermediate Similarity NPD8325 Phase 3
0.7082 Intermediate Similarity NPD8326 Phase 3
0.7082 Intermediate Similarity NPD8327 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD7707 Approved
0.7039 Intermediate Similarity NPD820 Phase 3
0.7033 Intermediate Similarity NPD1483 Discontinued
0.7013 Intermediate Similarity NPD7927 Clinical (unspecified phase)
0.6953 Remote Similarity NPD3795 Approved
0.6953 Remote Similarity NPD3794 Approved
0.6905 Remote Similarity NPD5088 Discontinued
0.6825 Remote Similarity NPD6635 Approved
0.6822 Remote Similarity NPD485 Clinical (unspecified phase)
0.6814 Remote Similarity NPD8485 Approved
0.681 Remote Similarity NPD2510 Approved
0.681 Remote Similarity NPD2509 Approved
0.6781 Remote Similarity NPD6529 Discontinued
0.6761 Remote Similarity NPD5891 Approved
0.6753 Remote Similarity NPD2831 Approved
0.6753 Remote Similarity NPD3947 Discontinued
0.6747 Remote Similarity NPD7885 Phase 2
0.6747 Remote Similarity NPD7886 Phase 2
0.6739 Remote Similarity NPD5721 Clinical (unspecified phase)
0.6725 Remote Similarity NPD8486 Clinical (unspecified phase)
0.6709 Remote Similarity NPD4506 Discontinued
0.6699 Remote Similarity NPD9271 Approved
0.6697 Remote Similarity NPD6642 Approved
0.6697 Remote Similarity NPD5751 Clinical (unspecified phase)
0.6697 Remote Similarity NPD6641 Approved
0.6696 Remote Similarity NPD8435 Approved
0.6695 Remote Similarity NPD7069 Discontinued
0.6681 Remote Similarity NPD3394 Approved
0.6681 Remote Similarity NPD3393 Approved
0.6681 Remote Similarity NPD3389 Approved
0.6681 Remote Similarity NPD6987 Phase 1
0.6667 Remote Similarity NPD2336 Approved
0.6667 Remote Similarity NPD6525 Clinical (unspecified phase)
0.6667 Remote Similarity NPD8409 Suspended
0.6653 Remote Similarity NPD4417 Approved
0.6653 Remote Similarity NPD4989 Phase 2
0.6652 Remote Similarity NPD7010 Phase 3
0.6639 Remote Similarity NPD3280 Approved
0.6639 Remote Similarity NPD8479 Phase 2
0.6638 Remote Similarity NPD53 Approved
0.6638 Remote Similarity NPD2121 Clinical (unspecified phase)
0.6638 Remote Similarity NPD7777 Approved
0.6638 Remote Similarity NPD7778 Approved
0.6625 Remote Similarity NPD7878 Phase 2
0.6624 Remote Similarity NPD6657 Clinical (unspecified phase)
0.6622 Remote Similarity NPD8361 Approved
0.6622 Remote Similarity NPD8360 Approved
0.6613 Remote Similarity NPD4373 Phase 2
0.6607 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6599 Remote Similarity NPD8372 Clinical (unspecified phase)
0.6598 Remote Similarity NPD3925 Approved
0.6592 Remote Similarity NPD8407 Phase 2
0.659 Remote Similarity NPD7708 Approved
0.6579 Remote Similarity NPD4427 Phase 2
0.6578 Remote Similarity NPD7233 Approved
0.6578 Remote Similarity NPD7234 Approved
0.6559 Remote Similarity NPD5801 Clinical (unspecified phase)
0.6553 Remote Similarity NPD7803 Approved
0.655 Remote Similarity NPD2307 Discontinued
0.6543 Remote Similarity NPD4301 Approved
0.6532 Remote Similarity NPD6962 Phase 2
0.6529 Remote Similarity NPD6770 Approved
0.6524 Remote Similarity NPD6477 Clinical (unspecified phase)
0.6522 Remote Similarity NPD9075 Approved
0.6522 Remote Similarity NPD9074 Approved
0.6515 Remote Similarity NPD3326 Clinical (unspecified phase)
0.6509 Remote Similarity NPD6026 Approved
0.6495 Remote Similarity NPD2511 Approved
0.6494 Remote Similarity NPD4987 Clinical (unspecified phase)
0.6494 Remote Similarity NPD3006 Discontinued
0.6492 Remote Similarity NPD4952 Phase 3
0.6485 Remote Similarity NPD8462 Phase 1
0.6478 Remote Similarity NPD4086 Phase 1
0.6475 Remote Similarity NPD8373 Clinical (unspecified phase)
0.6466 Remote Similarity NPD6661 Clinical (unspecified phase)
0.6462 Remote Similarity NPD8370 Discontinued
0.646 Remote Similarity NPD4948 Discontinued
0.6457 Remote Similarity NPD8368 Discontinued
0.6444 Remote Similarity NPD5475 Discontinued
0.6443 Remote Similarity NPD6825 Phase 1
0.6441 Remote Similarity NPD4901 Clinical (unspecified phase)
0.642 Remote Similarity NPD1926 Approved
0.6408 Remote Similarity NPD107 Approved
0.6392 Remote Similarity NPD6790 Phase 1
0.6389 Remote Similarity NPD8329 Phase 3
0.6375 Remote Similarity NPD7470 Discontinued
0.6371 Remote Similarity NPD6732 Clinical (unspecified phase)
0.6371 Remote Similarity NPD5640 Discontinued
0.6364 Remote Similarity NPD7955 Approved
0.6364 Remote Similarity NPD7956 Approved
0.636 Remote Similarity NPD8052 Clinical (unspecified phase)
0.6356 Remote Similarity NPD7962 Phase 2
0.6348 Remote Similarity NPD6665 Discontinued
0.6348 Remote Similarity NPD4376 Phase 3
0.6337 Remote Similarity NPD8466 Approved
0.6337 Remote Similarity NPD8465 Approved
0.6337 Remote Similarity NPD8467 Approved
0.6337 Remote Similarity NPD8160 Phase 2
0.6335 Remote Similarity NPD7688 Phase 1
0.6333 Remote Similarity NPD6262 Clinical (unspecified phase)
0.6333 Remote Similarity NPD4900 Clinical (unspecified phase)
0.6332 Remote Similarity NPD8063 Discontinued
0.6322 Remote Similarity NPD7571 Clinical (unspecified phase)
0.632 Remote Similarity NPD4551 Phase 2
0.632 Remote Similarity NPD6361 Phase 2
0.6318 Remote Similarity NPD7967 Discontinued
0.6316 Remote Similarity NPD6791 Phase 2
0.6316 Remote Similarity NPD6995 Phase 1
0.6311 Remote Similarity NPD8404 Phase 2
0.6303 Remote Similarity NPD4862 Clinical (unspecified phase)
0.6298 Remote Similarity NPD4396 Clinical (unspecified phase)
0.6296 Remote Similarity NPD4667 Clinical (unspecified phase)
0.6281 Remote Similarity NPD5866 Approved
0.6278 Remote Similarity NPD7799 Discontinued
0.6266 Remote Similarity NPD7061 Clinical (unspecified phase)
0.6264 Remote Similarity NPD8091 Phase 3
0.6261 Remote Similarity NPD5901 Discontinued
0.6261 Remote Similarity NPD6323 Clinical (unspecified phase)
0.626 Remote Similarity NPD7807 Clinical (unspecified phase)
0.6255 Remote Similarity NPD7862 Clinical (unspecified phase)
0.625 Remote Similarity NPD8356 Approved
0.6245 Remote Similarity NPD8459 Approved
0.6245 Remote Similarity NPD8426 Approved
0.6245 Remote Similarity NPD6257 Clinical (unspecified phase)
0.6245 Remote Similarity NPD8460 Approved
0.6245 Remote Similarity NPD8020 Approved
0.6245 Remote Similarity NPD8021 Approved
0.6245 Remote Similarity NPD8425 Approved
0.6239 Remote Similarity NPD5003 Discontinued
0.6239 Remote Similarity NPD6206 Phase 1
0.6239 Remote Similarity NPD3178 Discontinued
0.6232 Remote Similarity NPD2896 Discontinued
0.6231 Remote Similarity NPD8375 Approved
0.623 Remote Similarity NPD4897 Phase 2
0.623 Remote Similarity NPD5022 Discontinued
0.623 Remote Similarity NPD8374 Phase 3
0.6228 Remote Similarity NPD6241 Phase 1
0.6227 Remote Similarity NPD4174 Clinical (unspecified phase)
0.6226 Remote Similarity NPD1270 Approved
0.6221 Remote Similarity NPD5482 Discontinued
0.6218 Remote Similarity NPD5513 Phase 2
0.6218 Remote Similarity NPD8427 Approved
0.6218 Remote Similarity NPD8429 Approved
0.6218 Remote Similarity NPD6176 Phase 1
0.6218 Remote Similarity NPD8428 Approved
0.621 Remote Similarity NPD6298 Discontinued
0.621 Remote Similarity NPD5506 Approved
0.621 Remote Similarity NPD1631 Approved
0.621 Remote Similarity NPD5507 Approved
0.6204 Remote Similarity NPD5490 Discontinued
0.6202 Remote Similarity NPD7417 Discontinued
0.6202 Remote Similarity NPD7576 Discontinued
0.62 Remote Similarity NPD7269 Clinical (unspecified phase)
0.6192 Remote Similarity NPD3946 Clinical (unspecified phase)
0.619 Remote Similarity NPD2564 Approved
0.619 Remote Similarity NPD2565 Phase 2
0.6183 Remote Similarity NPD8371 Clinical (unspecified phase)
0.6183 Remote Similarity NPD8350 Clinical (unspecified phase)
0.618 Remote Similarity NPD4528 Approved
0.618 Remote Similarity NPD4529 Approved
0.618 Remote Similarity NPD4526 Approved
0.6179 Remote Similarity NPD8000 Clinical (unspecified phase)
0.6178 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6176 Remote Similarity NPD7187 Phase 2
0.6175 Remote Similarity NPD2581 Approved
0.6175 Remote Similarity NPD8289 Discontinued
0.6175 Remote Similarity NPD2582 Approved
0.6171 Remote Similarity NPD1575 Approved
0.6171 Remote Similarity NPD1573 Approved
0.6169 Remote Similarity NPD1996 Discontinued
0.6167 Remote Similarity NPD1783 Clinical (unspecified phase)
0.6167 Remote Similarity NPD7001 Phase 3
0.6164 Remote Similarity NPD3785 Clinical (unspecified phase)
0.6161 Remote Similarity NPD751 Clinical (unspecified phase)
0.616 Remote Similarity NPD4600 Approved
0.616 Remote Similarity NPD4601 Approved
0.616 Remote Similarity NPD4491 Clinical (unspecified phase)
0.6159 Remote Similarity NPD3217 Phase 2
0.6157 Remote Similarity NPD4889 Approved
0.6151 Remote Similarity NPD7497 Discontinued
0.6151 Remote Similarity NPD8430 Approved
0.6147 Remote Similarity NPD4334 Discontinued
0.6145 Remote Similarity NPD6276 Discontinued
0.6145 Remote Similarity NPD5147 Discontinued
0.6145 Remote Similarity NPD4923 Phase 1
0.6143 Remote Similarity NPD6739 Clinical (unspecified phase)
0.6141 Remote Similarity NPD3371 Approved
0.6141 Remote Similarity NPD7562 Approved
0.6137 Remote Similarity NPD4950 Approved
0.613 Remote Similarity NPD5483 Clinical (unspecified phase)
0.6129 Remote Similarity NPD7404 Approved
0.6128 Remote Similarity NPD6226 Phase 3
0.6123 Remote Similarity NPD5899 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data